BCHE and Alzheimer disease: Besides treatment with cholinesterase inhibitors, deep brain stimulation of the nbM came into focus as potentially promising treatment option for cognitive symptoms in patients with AD (Luo et al., 2021), LBD (Maltete et al., 2021), and PDD (Gratwicke et al., 2018).